Top

Published in:

01-02-2018 | Original Research

Blue Genes? Understanding and Mitigating Negative Consequences of Personalized Information about Genetic Risk for Depression

Authors: Matthew S. Lebowitz, Woo-kyoung Ahn

Published in: Journal of Genetic Counseling | Issue 1/2018

Abstract

Personalized genetic testing for vulnerability to mental disorders is expected to become increasingly common. It is therefore important to understand whether learning about one’s genetic risk for a mental disorder has negative clinical implications, and if so, how these might be counteracted. Among participants with depressive symptoms, we administered a sham biochemical test purportedly revealing participants’ level of genetic risk for major depression. Participants told that they carried a genetic predisposition to depression expressed significantly lower confidence in their ability to cope with depressive symptoms than participants told they did not carry this predisposition. A short intervention providing education about the non-deterministic nature of genes’ effects on depression fully mitigated this negative effect, however. Given the clinical importance of patient expectancies in depression, the notion that pessimism about one’s ability to overcome symptoms could be exacerbated by genetic information—which will likely become ever more widely available—represents cause for concern. Education and counseling about the malleability of genetic effects may be an important tool for counteracting clinically deleterious beliefs that can be evoked by genetic test results. Genetic counselors may be able to help patients avoid becoming demoralized by learning they have a genetic predisposition to depression by providing education about the non-deterministic role of biology in depression, and a brief audiovisual intervention appears to be an effective approach to delivering such education.

Available only for authorised users

Our modified version of the BDI-II demonstrated high internal consistency (reliability), Cronbach alpha = .94.

Participants could have provided low ratings of the saliva test’s accuracy and reliability for reasons other than suspicion of the test being fake—such as people’s tendency toward defensive processing of threatening health information (Etchegary and Perrier 2007), which may lead individuals to reject personalized messages that suggest they may be at risk for health problems. If this had been the reason some participants did not rate the saliva test as credible, though, there would likely have been more participants endorsing the credibility of the saliva test in the Gene-Absent condition than in the Gene-Present conditions (because the gene-absent feedback did not contain threatening information). On the contrary, among participants who scored at least 13 on the BDI-II there was no significant difference by condition in credibility ratings, F(2, 256) = .65, p = .53. Nonetheless, the present study did not directly measure the reasons people might have discredited the saliva test, and future research examining the causes of such reactions in depth would be highly valuable.

Ahn, W., Proctor, C. C., & Flanagan, E. H. (2009). Mental health Clinicians' beliefs about the biological, psychological, and environmental bases of mental disorders. Cognitive Science, 33(2), 147–182. doi:10.1111/J.1551-6709.2009.01008.X.PubMedPubMedCentralCrossRef

American Psychological Association. (2017). Ethical principles of psychologists and code of conduct. Retrieved from http://www.apa.org/ethics/code/ethics-code-2017.pdf

Aspinwall, L. G., Taber, J. M., Leaf, S. L., Kohlmann, W., & Leachman, S. A. (2013). Melanoma genetic counseling and test reporting improve screening adherence among unaffected carriers 2 years later. Cancer Epidemiology, Biomarkers and Prevention, 22(10), 1687.PubMedCrossRef

Austin, J. C., & Honer, W. G. (2005). The potential impact of genetic counseling for mental illness. Clinical Genetics, 67(2), 134–142. doi:10.1111/j.1399-0004.2004.00330.x.PubMedCrossRef

Austin, J. C., & Honer, W. G. (2007). The genomic era and serious mental illness: A potential application for psychiatric genetic counseling. Psychiatric Services, 58(2), 254–261. doi:10.1176/ps.2007.58.2.254.PubMedCrossRef

Baumrind, D. (1985). Research using intentional deception: Ethical issues revisited. American Psychologist, 40(2), 165–174. doi:10.1037/0003-066X.40.2.165.PubMedCrossRef

Beck, A. T., & Clark, D. A. (1988). Anxiety and depression: An information processing perspective. Anxiety Research, 1(1), 23–36. doi:10.1080/10615808808248218.CrossRef

Blackwell, L. S., Trzesniewski, K. H., & Dweck, C. S. (2007). Implicit theories of intelligence predict achievement across an adolescent transition: A longitudinal study and an intervention. Child Development, 78(1), 246–263.PubMedCrossRef

Boynton, M. H., Portnoy, D. B., & Johnson, B. T. (2013). Exploring the ethics and psychological impact of deception in psychological research. IRB, 35(2), 7–13.PubMedPubMedCentral

Buhrmester, M., Kwang, T., & Gosling, S. D. (2011). Amazon's mechanical Turk: A new source of inexpensive, yet high-quality, data? Perspectives on Psychological Science, 6(1), 3–5. doi:10.1177/1745691610393980.PubMedCrossRef

Catanzaro, S. J., & Mearns, J. (1990). Measuring generalized expectancies for negative mood regulation: Initial scale development and implications. Journal of Personality Assessment, 54, 546–563.PubMedCrossRef

Caulfield, T., Chandrasekharan, S., Joly, Y., & Cook-Deegan, R. (2013). Harm, hype and evidence: ELSI research and policy guidance. Genome Medicine, 5(3), 21–26. doi:10.1186/gm425.PubMedPubMedCentralCrossRef

Collins, R. E., Wright, A. J., & Marteau, T. M. (2011). Impact of communicating personalized genetic risk information on perceived control over the risk: A systematic review. Genetics in Medicine, 13(4), 273–277.PubMedCrossRef

Couzin, J. (2008). Gene tests for psychiatric risk polarize researchers. Science, 319(5861), 274–277. doi:10.1126/science.319.5861.274.PubMedCrossRef

Dar-Nimrod, I., & Heine, S. J. (2011). Genetic essentialism: On the deceptive determinism of DNA. Psychological Bulletin, 137(5), 800–818. doi:10.1037/a0021860.PubMedPubMedCentralCrossRef

Dar-Nimrod, I., Zuckerman, M., & Duberstein, P. R. (2013). The effects of learning about one’s own genetic susceptibility to alcoholism: A randomized experiment. Genetics in Medicine, 15(2), 132–138. doi:10.1038/gim.2012.111.PubMedCrossRef

Dozois, D. J. A. (2010). Beck depression inventory-II. In I. B. Weiner & W. E. Craighead (Eds.), The Corsini encyclopedia of psychology (4th ed.). New York, NY: Wiley.

Drmanac, R. (2011). The advent of personal genome sequencing. Genetics in Medicine, 13(3), 188–190. doi:10.1097/GIM.0b013e31820f16e6.PubMedCrossRef

Dweck, C. S. (2012). Mindsets and human nature: Promoting change in the Middle East, the schoolyard, the racial divide, and willpower. The American Psychologist, 67(8), 614–622. doi:10.1037/a0029783.PubMedCrossRef

Epley, N., & Huff, C. (1998). Suspicion, affective response, and educational benefit as a result of deception in psychology research. Personality and Social Psychology Bulletin, 24(7), 759–768. doi:10.1177/0146167298247008.CrossRef

Etchegary, H., & Perrier, C. (2007). Information processing in the context of genetic risk: Implications for genetic-risk communication. Journal of Genetic Counseling, 16(4), 419–432. doi:10.1007/s10897-006-9082-z.PubMedCrossRef

Frosch, D. L., Mello, P., & Lerman, C. (2005). Behavioral consequences of testing for obesity risk. Cancer Epidemiology, Biomarkers & Prevention, 14(6), 1485–1489. doi:10.1158/1055-9965.epi-04-0913.CrossRef

Gershon, E. S., & Alliey-Rodriguez, N. (2013). New ethical issues for genetic counseling in common mental disorders. American Journal of Psychiatry, 170(9), 968–976. doi:10.1176/appi.ajp.2013.12121558.PubMedCrossRef

Gotlib, I. H., & Joormann, J. (2010). Cognition and depression: Current status and future directions. Annual Review of Clinical Psychology, 6, 285–312. doi:10.1146/annurev.clinpsy.121208.131305.PubMedPubMedCentralCrossRef

Harris, A., Kelly, S. E., & Wyatt, S. (2013). Counseling customers: Emerging roles for genetic counselors in the direct-to-consumer genetic testing market. Journal of Genetic Counseling, 22(2), 277–288. doi:10.1007/s10897-012-9548-0.PubMedCrossRef

Haslam, N. (2011). Genetic essentialism, neuroessentialism, and stigma: Commentary on Dar-nimrod and Heine (2011). Psychological Bulletin, 137(5), 819–824.PubMedCrossRef

Hertwig, R., & Ortmann, A. (2008). Deception in experiments: Revisiting the arguments in its defense. Ethics & Behavior, 18(1), 59–92. doi:10.1080/10508420701712990.CrossRef

Higgins, E. T. (1999). 'Saying is believing' effects: When sharing reality about something biases knowledge and evaluations. In J. M. Levine, D. M. Messick, & L. L. Thompson (Eds.), Shared cognition in organizations: The management of knowledge (1st ed., pp. 33–49). Mahwah, NJ: Lawrence Erlbaum Associates Inc..

Hippman, C., Ringrose, A., Inglis, A., Cheek, J., Albert, A. Y. K., Remick, R., et al. (2016). A pilot randomized clinical trial evaluating the impact of genetic counseling for serious mental illnesses. Journal of Clinical Psychiatry, 77(2), e190–e198. doi:10.4088/JCP.14m09710.PubMedPubMedCentralCrossRef

Hogarth, S., Javitt, G., & Melzer, D. (2008). The current landscape for direct-to-consumer genetic testing: Legal, ethical, and policy issues. Annual Review of Genomics and Human Genetics, 9(1), 161–182. doi:10.1146/annurev.genom.9.081307.164319.PubMedCrossRef

Hollands, G. J., French, D. P., Griffin, S. J., Prevost, A. T., Sutton, S., King, S., et al. (2016). The impact of communicating genetic risks of disease on risk-reducing health behaviour: Systematic review with meta-analysis. British Medical Journal, 352, i1102.

Hudson, K., Javitt, G., Burke, W., Byers, P., & Committee, A. S. I. (2007). ASHG statement on direct-to-consumer genetic testing in the United States. American Journal of Human Genetics, 81(3), 635–637.PubMedCentralCrossRef

Jemmott, J. B., Ditto, P. H., & Croyle, R. T. (1986). Judging health status: Effects of perceived prevalence and personal relevance. Journal of Personality and Social Psychology, 50(5), 899–905. doi:10.1037/0022-3514.50.5.899.PubMedCrossRef

Kemp, J. J., Lickel, J. J., & Deacon, B. J. (2014). Effects of a chemical imbalance causal explanation on individuals’ perceptions of their depressive symptoms. Behaviour Research and Therapy, 56, 47–52. doi:10.1016/j.brat.2014.02.009.PubMedCrossRef

Krell, H. V., Leuchter, A. F., Morgan, M., Cook, I. A., & Abrams, M. (2004). Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. Journal of Clinical Psychiatry, 65(9), 1174–1179. doi:10.4088/JCP.v65n0904.PubMedCrossRef

Kvaale, E. P., Haslam, N., & Gottdiener, W. H. (2013). The 'side effects' of medicalization: A meta-analytic review of how biogenetic explanations affect stigma. Clinical Psychology Review, 33(6), 782–794. doi:10.1016/j.cpr.2013.06.002.PubMedCrossRef

Lebowitz, M. S., & Ahn, W. (2015). Emphasizing malleability in the biology of depression: Durable effects on perceived agency and prognostic pessimism. Behaviour Research and Therapy, 71, 125–130.PubMedPubMedCentralCrossRef

Lebowitz, M. S., Ahn, W. K., & Nolen-Hoeksema, S. (2013). Fixable or fate? Perceptions of the biology of depression. Journal of Consulting and Clinical Psychology, 81(3), 518–527. doi:10.1037/a0031730.PubMedPubMedCentralCrossRef

Madlensky, L., Trepanier, A. M., Cragun, D., Lerner, B., Shannon, K. M., & Zierhut, H. (2017). A rapid systematic review of outcomes studies in genetic counseling. Journal of Genetic Counseling, 1–18. doi:10.1007/s10897-017-0067-x.

Marteau, T., Senior, V., Humphries, S. E., Bobrow, M., Cranston, T., Crook, M. A., et al. (2004). Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial. American Journal of Medical Genetics Part A, 128A(3), 285–293. doi:10.1002/ajmg.a.30102.PubMedCrossRef

McBride, C. M., Koehly, L. M., Sanderson, S. C., & Kaphingst, K. A. (2010). The behavioral response to personalized genetic information: Will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annual Review of Public Health, 31(1), 89–103. doi:10.1146/annurev.publhealth.012809.103532.PubMedCrossRef

Meiser, B., Peate, M., Levitan, C., Mitchell, P. B., Trevena, L., Barlow-Stewart, K., et al. (2016). A psycho-educational intervention for people with a family history of depression: Pilot results. Journal of Genetic Counseling, 1–10. doi:10.1007/s10897-016-0011-5.

Meyer, B., Pilkonis, P. A., Krupnick, J. L., Egan, M. K., Simmens, S. J., & Sotsky, S. M. (2002). Treatment expectancies, patient alliance and outcome: Further analyses from the National Institute of Mental Health treatment of depression collaborative research program. Journal of Consulting and Clinical Psychology, 70(4), 1051–1055. doi:10.1037//0022-006x.70.4.1051.PubMedCrossRef

Miu, A. S., & Yeager, D. S. (2015). Preventing symptoms of depression by teaching adolescents that people can change: effects of a brief incremental theory of personality intervention at 9-month follow-up. Clinical Psychological Science, 3(5), 726–743.

Ortmann, A., & Hertwig, R. (2002). The costs of deception: Evidence from psychology. Experimental Economics, 5(2), 111–131. doi:10.1023/A:1020365204768.CrossRef

Persky, S., Kaphingst, K. A., Condit, C. M., & McBride, C. M. (2007). Assessing hypothetical scenario methodology in genetic susceptibility testing analog studies: A quantitative review. Genetics in Medicine, 9(11), 727–738.PubMedCrossRef

Pescosolido, B. A., Martin, J. K., Long, J. S., Medina, T. R., Phelan, J. C., & Link, B. G. (2010). "a disease like any other"? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. The American Journal of Psychiatry, 167(11), 1321–1330. doi:10.1176/appi.ajp.2010.09121743.PubMedPubMedCentralCrossRef

Phelan, J. C., Yang, L. H., & Cruz-Rojas, R. (2006). Effects of attributing serious mental illnesses to genetic causes on orientations to treatment. Psychiatric Services, 57(3), 382–387. doi:10.1176/appi.ps.57.3.382.PubMedCrossRef

Rutherford, B. R., Wager, T. D., & Roose, S. P. (2010). Expectancy and the treatment of depression: A review of experimental methodology and effects on patient outcome. Current Psychiatry Reviews, 6(1), 1–10. doi:10.2174/157340010790596571.PubMedPubMedCentralCrossRef

Rutherford, S., Zhang, X., Atzinger, C., Ruschman, J., & Myers, M. F. (2014). Medical management adherence as an outcome of genetic counseling in a pediatric setting. Genetics in Medicine, 16(2), 157–163. doi:10.1038/gim.2013.90.PubMedCrossRef

Sanderson, S. C., Persky, S., & Michie, S. (2010). Psychological and behavioral responses to genetic test results indicating increased risk of obesity: Does the causal pathway from gene to obesity matter? Public Health Genomics, 13(1), 34–47.PubMedCrossRef

Simon, G. E., & Perlis, R. H. (2010). Personalized medicine for depression: Can we match patients with treatments? American Journal of Psychiatry, 167(12), 1445–1455. doi:10.1176/appi.ajp.2010.09111680.PubMedPubMedCentralCrossRef

Taber, J. M., Aspinwall, L. G., Stump, T. K., Kohlmann, W., Champine, M., & Leachman, S. A. (2015). Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone. Journal of Behavioral Medicine, 38(5), 740–753. doi:10.1007/s10865-015-9648-z.PubMedPubMedCentralCrossRef

Uher, R., Perroud, N., Ng, M. Y. M., Hauser, J., Henigsberg, N., Maier, W., et al. (2010). Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. American Journal of Psychiatry, 167(5), 555–564. doi:10.1176/appi.ajp.2009.09070932.PubMedCrossRef

Uz, I., & Kemmelmeier, M. (2016). Can deception be desirable? Social Science Information, 56(1), 98–106. doi:10.1177/0539018416675070.CrossRef

Walton, G. M., & Cohen, G. L. (2011). A brief social-belonging intervention improves academic and health outcomes of minority students. Science, 331(6023), 1447.PubMedCrossRef

Williams, L. M., Rush, A. J., Koslow, S. H., Wisniewski, S. R., Cooper, N. J., Nemeroff, C. B., et al. (2011). International study to predict optimized treatment for depression (iSPOT-D), a randomized clinical trial: Rationale and protocol. Trials, 12(1), 4. doi:10.1186/1745-6215-12-4.PubMedPubMedCentralCrossRef

Title: Blue Genes? Understanding and Mitigating Negative Consequences of Personalized Information about Genetic Risk for Depression
Authors: Matthew S. Lebowitz
Woo-kyoung Ahn
Publication date: 01-02-2018
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 1/2018
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-017-0140-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Blue Genes? Understanding and Mitigating Negative Consequences of Personalized Information about Genetic Risk for Depression

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

National Society of Genetic Counselors Code of Ethics: Explication of 2017 Revisions

Counseling Close to Home: Genetic Counselors’ Experiences with their own Family Members

Patients’ Knowledge of Prenatal Screening for Trisomy 21

Invasive Prenatal Diagnostic Testing Recommendations are Influenced by Maternal Age, Statistical Misconception and Perceived Liability

Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies

National Society of Genetic Counselors Code of Ethics